Saniona Investor Relations Material

Saniona AB is a clinical-stage biopharmaceutical company based in Denmark, focused on the discovery and development of treatments for central nervous system, autoimmune, metabolic diseases, and pain management. The company specializes in modulating ion channels, a class of proteins critical in cellular signaling. Saniona has built a proprietary drug discovery platform that includes more than 20,000 ion channel-modulating molecules. The company is headquartered in Ballerup, Denmark, and its shares are listed on the Nasdaq Stockholm.